Leslie M. Turner
Known title: DirectorCIK: 0001553405
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FirstEnergy Q3 Outlook Positive Amid AI Power Demand. FirstEnergy expects third-quarter core earnings to rise due to higher investment and rates, according to BofA. The company is also benefiting from increased power demand driven by AI data centers. Barclays maintains an Overweight rating but lowered its price target to $49. These developments highlight the utility's role in the growing energy infrastructure market.
Transaction History
| CC | ▲ Buy | Grant | 7,182 | $0 | 5/6/2026 | View on chart |
| FE | ▲ Buy | Grant | 944 | $42K | 1/2/2026 | View on chart |
| FE | ▲ Buy | Grant | 925 | $42K | 10/1/2025 | View on chart |
| FE | ▲ Buy | Grant | 1,055 | $42K | 7/1/2025 | View on chart |
| CC | ▲ Buy | Grant | 14,096 | $0 | 4/22/2025 | View on chart |
| FE | ▲ Buy | Grant | 1,056 | $42K | 4/1/2025 | View on chart |
| CC | ▲ Buy | Grant | 2,886 | $0 | 3/3/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Chemours Q2 Earnings Call and UBS Price Target Cut
Chemours released its Q2 2026 earnings call transcript, providing details on its financial performance. UBS kept a neutral stance but lowered its price target to $16, reflecting a more cautious view of the company's outlook. The new target sits below the current average analyst target of $18.22 and near the support level of $15.07, indicating a potential short‑term pressure on the stock.
Chemours Q2 Earnings Call and UBS Price Target Cut. Chemours released its Q2 2026 earnings call transcript, providing details on its financial performance. UBS kept a neutral stance but lowered its price target to $16, reflecting a more cautious view of the company's outlook. The new target sits below the current average analyst target of $18.22 and near the support level of $15.07, indicating a potential short‑term pressure on the stock.